Filter Results:
(563)
Show Results For
- All HBS Web
(563)
- People (4)
- News (151)
- Research (350)
- Events (2)
- Multimedia (4)
- Faculty Publications (172)
Show Results For
- All HBS Web
(563)
- People (4)
- News (151)
- Research (350)
- Events (2)
- Multimedia (4)
- Faculty Publications (172)
- 23 Aug 2016
- First Look
August 23, 2016
science education from around the world as they discuss regional trends and models, with a specific focus on developments in and cooperation with China. Focusing on why this model responds to the twenty-first century requirements for... View Details
Keywords: Sean Silverthorne
- 08 Nov 2016
- First Look
November 8, 2016
and models, with a specific focus on developments in and cooperation with China. Focusing on why this model responds to the twenty-first century requirements for excellence and relevance in undergraduate education, contributors examine if... View Details
Keywords: Sean Silverthorne
- 15 Jan 2013
- First Look
First Look: January 15
company was hurt by long delays in bringing Bydureon, a once-a-week version of Byetta, to market, which allowed a competitor time to establish itself in the once-a-week market. Amylin also failed to develop a marketable anti-obesity View Details
Keywords: Sean Silverthorne
- 31 Jan 2017
- First Look
First Look at New Research: January 31, 2017
Abstract—The Food and Drug Administration approves new medical devices after in-depth reviews of safety and effectiveness data. Some have advocated for shorter review times to encourage innovation. We evaluated whether regulatory review... View Details
Keywords: Carmen Nobel
- 24 Jun 2016
- News
Reinventing Pharma
2004) began her career as a research scientist. Eventually expanding her responsibilities into business development led her to HBS, where she hoped to solidify her understanding of the intersection of science and business. Following... View Details
- 01 Dec 2013
- News
To Market, to Market
chirality) of drug molecules with a high degree of accuracy for drug development and diagnostic applications. Chemical compounds excreted by predators that stimulate avoidance... View Details
- 14 May 2014
- News
(Re)moving the Needle
You wouldn't think that the lowly, annoying mosquito would have anything to teach researchers working on the cutting edge of drug delivery methodology, but you would be wrong. Have you ever noticed that you don't become aware of a... View Details
- 24 Sep 2020
- News
The Race for a Vaccine
newly opened facility to accommodate its vaccine development work, and CEO Stéphane Bancel (MBA 2000, AMP 170) welcomed input on the design from the government’s infectious disease experts. For two years, Moderna had been working closely... View Details
- 20 Aug 2014
- News
With No Time to Lose
into ALS research, and removed some critical barriers to the development of treatments. “Our focus, from the start, was to get drug companies to invest money in ALS,” says Kremer, who was diagnosed with the... View Details
Keywords: Margie Kelley
- 01 Sep 2008
- News
Mara Aspinall
pharmaceutical companies focused their R&D on treatments for common illnesses — such as diabetes and high cholesterol — an approach that resulted in the development of blockbuster drugs. We now recognize that diseases are far more complex... View Details
- 01 Dec 2013
- News
Your Own Medicine
million to have the biotech develop it as a potential cancer drug, eventually giving up when even low doses resulted in severe nausea during clinical trials. Still, the drug became a focal point for the... View Details
- Profile
Henry McCance
a few FDA-approved drugs for Alzheimer’s disease, and they won’t help,’” he recalls. McCance, a venture- capital pioneer with Greylock Partners, had spent 40 years as eyewitness to advances in technology that changed the world at... View Details
- 01 Dec 2019
- News
The Race Against Resistance
the hospital, which we can then use to price our drug appropriately,” Kimble says. Kimble and Triola also stress the importance of developing antibiotics that can be used both in a hospital setting and at... View Details
Keywords: Lisa Scanlon Mogolov
- 29 May 2001
- Research & Ideas
Genomics: Can We Start Making Money Now?
said. The potential influence on drug development in particular, and medicine in general, is enormous, panelists agreed. Today's drugs can reach some 400 to 500 potential... View Details
Keywords: by Sean Silverthorne
- 01 Mar 2012
- News
How to Close the Health Gap
companies largely ignored the world’s poor: few new drugs were created to combat tropical diseases and TB. The needs of the developing world also were neglected by the Human Genome Project, one of the great... View Details
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
developments suggest that doctors will eventually be able to treat patients more effectively with medicine tailored to their genetic makeup, including, in some cases, gene replacement therapies. "The View Details
- 01 Mar 2016
- News
Off Script
(Thinkstock) Prescription drug spending increased by more than 13 percent in the United States in 2014, raising health insurance premiums and the ire of consumers and politicians. The reasons behind the rise are many, including the high... View Details
- 01 Jun 2009
- Lessons from the Classroom
The Challenges of Investing in Science-Based Innovation
she adds, with the development of a vaccine against cervical cancer (Gardasil) and the launch of successful new drugs to combat diabetes and HIV/AIDS. Sato acknowledges that different situations will require... View Details
- Fast Answer
Pharmaceuticals: Pipeline
Profiles cover detailed information such as alternative names, therapeutic uses, FDA actions and licensing changes, companies associated with development of the drug, etc. To begin a search, use the function BI PHRM DEX, select... View Details
- 13 Oct 2016
- News
Adding Muscle to the Fight Against Disease
graduation from Harvard Business School and which successfully developed and commercialized a market-leading drug to treat cardiovascular disease. But in addition to drawing on technical degrees and... View Details
Keywords: Deborah Blagg